Phase I Trial of the Oral Poly (ADP-ribose) Polymerase (PARP) Inhibitor Veliparib (ABT-888, V) Combined Wtih Topoecan (T) and Carboplatin (C) for Adults with Relapsed and Refractory Acute Leukemias
Author:
Judith E. Karp,Keith W Pratz,Mark R. Litzow,Jiuping Ji,Alice Chen,Michelle Rudek,Scott H. Kaufmann
Copyright © 2010 American Society of Hematology